These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35218940)

  • 21. Treatment of actinic cheilitis by photodynamic therapy with 5-aminolevulinic acid and blue light activation.
    Zaiac M; Clement A
    J Drugs Dermatol; 2011 Nov; 10(11):1240-5. PubMed ID: 22052302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
    Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
    Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daylight photodynamic therapy: the Southern California experience.
    Lane KL; Hovenic W; Ball K; Zachary CB
    Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
    Fu C; Kuang BH; Qin L; Zeng XY; Wang BC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():408-414. PubMed ID: 31310826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients.
    Fai D; Romano I; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2012 Feb; 147(1):99-101. PubMed ID: 22370573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases.
    Hauschild A; Lischner S; Lange-Asschenfeldt B; Egberts F
    Dermatol Surg; 2005 Oct; 31(10):1344-7, discussion 1348. PubMed ID: 16188193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.
    Zhang G; Cao Z; Wang P; Zhu L; Zhang L; Zho Z; Shi L; Wang X
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101605. PubMed ID: 31786334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
    Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for the treatment of actinic cheilitis.
    Kodama M; Watanabe D; Akita Y; Tamada Y; Matsumoto Y
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):209-10. PubMed ID: 17803601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
    Galimberti GN
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on photodynamic treatment for actinic keratosis.
    Wiegell SR
    Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities.
    Piaserico S; Piccioni A; Gutiérrez Garcìa-Rodrigo C; Sacco G; Pellegrini C; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102325. PubMed ID: 33965603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy of photodynamic therapy for the treatment of actinic cheilitis.
    Chaves YN; Torezan LA; Lourenço SV; Neto CF
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):14-21. PubMed ID: 27864997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
    Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.